Zinc gluconate is an agonist of peroxisome proliferator‐activated receptor‐α in the epidermis

Abstract

Peroxisome proliferator-activated receptors-α (PPARs-α) are nuclear receptors with anti-inflammatory properties. Zinc gluconate is efficient in the treatment of several inflammatory dermatoses. The aim of our work was to determine whether the modulation of PPAR-α expression and activity could be one of the mechanisms of action of zinc gluconate anti-inflammatory activity in inflammatory dermatoses. Thus, we used ex vivo skin explants incubated with lipopolysaccharide (LPS), a pro-inflammatory molecule, with or without zinc gluconate. We evaluated PPAR-α protein expression using immunohistochemistry, PPAR-α DNA-binding activity using an ELISA-like technique, and PPAR-α mRNA levels using quantitative PCR. On the one hand, we found that PPAR-α epidermal protein expression was stimulated by LPS and that LPS suppressed PPAR-α mRNA expression, without modifying its function. On the other hand, in inflammatory LPS-stimulated explants, zinc gluconate significantly upregulated PPAR-α function and mRNA expression level, without changing its epidermal protein expression. These results suggest that zinc gluconate may be a PPAR-α agonist, which might play a role in the anti-inflammatory activity of this molecule.

The Role of Moisturizers in Addressing Various Kinds of Dermatitis: A Review

“…Recent evidence shows that its antiinflammatory effects may target at peroxisome proliferatoractivated receptors-α (PPARs-α), human β-defensin-2, and psoriasin. 57,58 Several examples of nonsteroidal, noncalcineurin inhibitor agents are now available. 59 MAS063DP was the first approved by the U.S. Food and Drug Administration to alleviate atopic dermatitis and allergic contact dermatitis symptoms.…”

The role of PPARγ‐mediated signalling in skin biology and pathology: new targets and opportunities for clinical dermatology

“…A major challenge for future research in the field is to dissect how the many different signalling pathways regulated by PPAR γ activation can be targeted more selectively, and differentially promoted or inhibited, depending on the desired clinical outcome. This can instructively be explored in available human cell culture, skin and organ culture models , as well as in appropriate animal models for different specific modulators . To shorten the time frame from ‘bench to bedside’, clinical studies on human material will have to be performed in parallel to the laboratory work.…”

Moisturizers for Patients with Atopic Dermatitis: An Overview

“…It has been shown to be efficient to treat inflammatory skin diseases such as acne vulgaris. Recent studies revealed that its antiinflammatory effects may target at peroxisome proliferator-activated receptors-α (PPARs-α), human β-defensin-2, and psoriasin [51,52].…”